Literature DB >> 15361850

Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors.

Yukinari Kato1, Isoji Sasagawa, Mika Kaneko, Motoki Osawa, Naoya Fujita, Takashi Tsuruo.   

Abstract

Aggrus (also known as T1alpha/podoplanin) is a membrane sialoglycoprotein whose function in tumors is unknown. We recently determined that Aggrus possessed the ability of inducing platelet aggregation and that its expression was frequently upregulated in colorectal tumors. Thus, Aggrus expression might be associated with tumor-induced platelet aggregation and tumor metastasis. Here we show, by means of cancer profiling array and real-time PCR, that aggrus mRNA expression is frequently upregulated in testicular germ cell tumors when compared with the surrounding normal tissue. Immunohistochemical staining revealed that Aggrus protein expression was detected in 10 of 11 seminomas (90.9%), but its expression was not observed in embryonal carcinomas (0/4; 0%). Specific markers for seminomas have not been reported, and Aggrus is a potential diagnostic marker for seminomas and may be associated with malignancies of the testis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361850     DOI: 10.1038/sj.onc.1207869

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

2.  Podoplanin is expressed in subsets of tumors of the central nervous system.

Authors:  Junji Shibahara; Takeshi Kashima; Yoshinao Kikuchi; Akiko Kunita; Masashi Fukayama
Journal:  Virchows Arch       Date:  2006-01-13       Impact factor: 4.064

3.  Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours.

Authors:  Si Brask Sonne; Amy S Herlihy; Christina E Hoei-Hansen; John E Nielsen; Kristian Almstrup; Niels E Skakkebaek; Alexander Marks; Henrik Leffers; Ewa Rajpert-De Meyts
Journal:  Virchows Arch       Date:  2006-05-31       Impact factor: 4.064

4.  Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.

Authors:  Xue-Cheng Bi; Jiu-Min Liu; Hui-Chang He; Yong-Kang Ye; Zhao-Dong Han; Qi-Shan Dai; Yu-Xiang Liang; Chao Cai; Jia-Hong Chen; Xi-Bin Chen; Guo-Qiang Qin; Guo-Hua Zeng; Wei-De Zhong
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

Review 5.  Podoplanin: a novel regulator of tumor invasion and metastasis.

Authors:  Qi Dang; Jie Liu; Juan Li; Yuping Sun
Journal:  Med Oncol       Date:  2014-08-21       Impact factor: 3.064

6.  Podoplanin is a negative regulator of Th17 inflammation.

Authors:  Alyssa N Nylander; Gerald D Ponath; Pierre-Paul Axisa; Mayyan Mubarak; Mary Tomayko; Vijay K Kuchroo; David Pitt; David A Hafler
Journal:  JCI Insight       Date:  2017-09-07

7.  Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification.

Authors:  Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Izumi Asahina; Tohru Ikeda
Journal:  Pathol Oncol Res       Date:  2013-11-28       Impact factor: 3.201

Review 8.  Podoplanin - a small glycoprotein with many faces.

Authors:  Maciej Ugorski; Piotr Dziegiel; Jaroslaw Suchanski
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

9.  The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.

Authors:  Akiko Kunita; Takeshi G Kashima; Yasuyuki Morishita; Masashi Fukayama; Yukinari Kato; Takashi Tsuruo; Naoya Fujita
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

10.  A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival.

Authors:  Eduardo Méndez; John R Houck; David R Doody; Wenhong Fan; Pawadee Lohavanichbutr; Tessa C Rue; Bevan Yueh; Neal D Futran; Melissa P Upton; D Gregory Farwell; Patrick J Heagerty; Lue Ping Zhao; Stephen M Schwartz; Chu Chen
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.